Pierre-Yves Dietrich
Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy
Espeli V, Vergotte S, Dietrich P, Pichard C, Siano M. Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy. Nutr Cancer 2018:1-6.
01.10.2018Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy
01.10.2018Nutr Cancer 2018:1-6
Espeli Vittoria, Vergotte Stephanie, Dietrich Pierre-Yves, Pichard Claude, Siano Marco
Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland
Steiner R, The Swiss Transplant Cohort Study Stcs, Koller M, Haralamvieva E, Cogliatti S, Binet F, Tinguely M, Fehr T, de Leval L, Schuurmans M, Dickenmann M, Manuel O, Mueller N, Achermann R, McKee T, Giostra E, Kridel R, Dietrich P. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland. Swiss Med Wkly 2018; 148:w14596.
08.03.2018Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland
08.03.2018Swiss Med Wkly 2018; 148:w14596
Steiner Raphael, The Swiss Transplant Cohort Study Stcs, Koller Michael, Haralamvieva Eugenia, Cogliatti Sergio, Binet Françoise-Isabelle, Tinguely Marianne, Fehr Thomas, de Leval Laurence, Schuurmans Macé M, Dickenmann Michael, Manuel Oriol, Mueller Nicolas, Achermann Rita, McKee Thomas, Giostra Emiliano, Kridel Robert, Dietrich Pierre-Yves
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
Templeton A, Schiess R, Wild P, Rüschoff J, Thalmann G, Dietrich P, Aebersold R, Klingbiel D, Gillessen Sommer S, Müller B, Winterhalder R, Stenner F, Dutoit V, Cathomas R, Rothermundt C, Bärtschi D, Dröge C, Gautschi O, Borner M, Fechter E, Swiss Group for Clinical Cancer Research (SAKK). Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08). Eur Urol 2013; 64:150-8.
06.04.2013Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
06.04.2013Eur Urol 2013; 64:150-8
Templeton Arnoud, Schiess Ralph, Wild Peter J, Rüschoff Jan H, Thalmann George, Dietrich Pierre-Yves, Aebersold Ruedi, Klingbiel Dirk, Gillessen Sommer Silke, Müller Beat, Winterhalder Ralph, Stenner Frank, Dutoit Valérie, Cathomas Richard, Rothermundt Christian, Bärtschi Daniela, Dröge Cornelia, Gautschi Oliver, Borner Markus, Fechter Eva, Swiss Group for Clinical Cancer Research (SAKK)
Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy
Neidert M, Dietrich P, Herold-Mende C, Rammensee H, Honegger J, Melms A, Christ L, Trautwein N, Trautwein C, Schoor O, Stevanovic S. Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy. J Neurooncol 2012; 111:285-94.
23.12.2012Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy
23.12.2012J Neurooncol 2012; 111:285-94
Neidert Marian Christoph, Dietrich Pierre-Yves, Herold-Mende Christel, Rammensee Hans-Georg, Honegger Jürgen, Melms Arthur, Christ Lisa, Trautwein Nico, Trautwein Claudia, Schoor Oliver, Stevanovic Stefan
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma
Renner C, Lohri A, Gyan E, Biaggi C, Cogliatti S, Bertoni F, Ghielmini M, Brauchli P, Ketterer N, Bouabdallah K, Trojan A, Zinzani P, Gressin R, Klingbiel D, Dietrich P, Hitz F, Bargetzi M, Mingrone W, Martinelli G, Swiss SAKK and French GOELAMS group from European Mantle Cell Lymphoma Network. A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica 2012; 97:1085-91.
07.02.2012A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma
07.02.2012Haematologica 2012; 97:1085-91
Renner Christoph, Lohri Andreas, Gyan Emmanuel, Biaggi Christine, Cogliatti Sergio B., Bertoni Francesco, Ghielmini Michele, Brauchli Peter, Ketterer Nicolas, Bouabdallah Krimo, Trojan Andreas, Zinzani Pier Luigi, Gressin Rémy, Klingbiel Dirk, Dietrich Pierre-Yves, Hitz Felicitas, Bargetzi Mario, Mingrone Walter, Martinelli Giovanni, Swiss SAKK and French GOELAMS group from European Mantle Cell Lymphoma Network
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98
Martinelli G, Zucca E, Dietrich P, Lohri A, Vorobiof D, Heizmann M, Stahel R, Stupp R, Okkinga E, Bassi S, Hess U, Cerny T, Utiger U, Schmitz S, Ghielmini M. Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98. J Clin Oncol 2010; 28:4480-4.
09.08.2010Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98
09.08.2010J Clin Oncol 2010; 28:4480-4
Martinelli Giovanni, Zucca Emanuele, Dietrich Pierre-Yves, Lohri Andreas, Vorobiof Daniel, Heizmann Marc, Stahel Rolf, Stupp Roger, Okkinga Emmie, Bassi Simona, Hess Urs, Cerny Thomas, Utiger Urs, Schmitz Shu-Fang Hsu, Ghielmini Michele
Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels
Rochlitz C, Dietrich P, Herrmann R, Morant R, Heinzerling L, Escudier B, Baudin M, Acres B, Squiban P, Cavalli F, Jantscheff P, Dreno B, Dummer R. Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels. Cancer gene therapy 2002; 9:289-95.
01.03.2002Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels
01.03.2002Cancer gene therapy 2002; 9:289-95
Rochlitz Christoph, Dietrich Pierre-Yves, Herrmann Richard, Morant Rudolf, Heinzerling Lucie, Escudier Bernard, Baudin Martine, Acres Bruce, Squiban Patrick, Cavalli Franco, Jantscheff Peter, Dreno Brigitte, Dummer Reinhard